Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Pep-therapy S.A.S.

Headquarters: Evry, France
Year Founded: 2014
Status: Private

BioCentury | Oct 3, 2017
Distillery Therapeutics

Other

BioCentury | Jun 15, 2017
Tools & Techniques

Breaking the barrier

Companies are finally finding ways to develop cell-penetrating biologics
BioCentury | Jan 18, 2017
Translation in Brief

Keep a cool head

Neuro Pharmalogics is exploiting insect biology for orphan neurological diseases
BioCentury | Nov 2, 2015
Emerging Company Profile

Targeted disruption

PEP-Therapy's peptides block specific protein-protein interactions
BioCentury | Jul 27, 2015
Company News

CleveXel Pharma, PEP-Therapy deal

BioCentury | May 4, 2015
Financial News

PEP-Therapy completes venture financing

Items per page:
1 - 6 of 6